• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

schulberg.j@unimelb.edu.au

Credentials


Position
Clinical (Fellow)
Department of Medicine

Mr Julien Schulberg

Clinical (Fellow)
Department of Medicine

27 Scholarly works
0 Projects

HIGHLIGHTS

  • 2025

    Journal article

    Crohn’s Disease Stricture Response to Treatment Assessed with Magnetic Resonance Imaging and Intestinal Ultrasound: STRIDENT Randomized Trial
    DOI: 10.1093/ibd/izaf073
  • 2025

    Journal article

    Intensified and Accelerated Rescue Infliximab Therapy for Acute Severe Ulcerative Colitis in Pregnancy: A Case Report
    DOI: 10.1002/jgh3.70091
  • 2025

    Journal article

    Repeated endoscopic dilation and needle-knife stricturotomy for Crohn's disease strictures
    DOI: 10.1016/j.gie.2024.09.031
  • 2024

    Journal article

    Gastrointestinal bleeding in Crohn's disease due to Epstein–Barr virus-positive mucocutaneous ulcer
    DOI: 10.1111/ans.19278
  • 2024

    Journal article

    6-Thioguanine nucleotide levels are associated with infliximab but not adalimumab levels in inflammatory bowel disease patients on combination therapy
    DOI: 10.1111/imj.16504
  • 2024

    Journal article

    Outcomes of a Comprehensive Specialist Inflammatory Bowel Disease Nursing Service
    DOI: 10.1093/ibd/izad145
  • 2024

    Journal article

    Intestinal Ultrasound and MRI for Monitoring Therapeutic Response in Luminal Crohn's Disease: A Systematic Review
    DOI: 10.1016/j.jacr.2023.09.010
Julien Schulberg

RECENT SCHOLARLY WORKS

  • 2024

    Journal article

    Risk factors for malignancy and serious infection in patients with inflammatory bowel disease: a retrospective analysis
    DOI: 10.1111/imj.16141
  • 2024

    Journal article

    Adalimumab Clearance, Rather Than Trough Level, May Have Greatest Relevance to Crohn’s Disease Therapeutic Outcomes Assessed Clinically and Endoscopically
    DOI: 10.1093/ecco-jcc/jjad140
  • 2024

    Journal article

    Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-α
    DOI: 10.3389/fimmu.2024.1342477

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224